Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients

<div>Serum sST2 concentrations were increased in AR patients than in healthy controls. (a) sST2 levels were elevated in the AR group in comparison with the HC group; (b) the serum sST2 levels were higher in the MSAR group than in the MAR and the HC group. sST2: soluble suppressor of tumorigenicity 2; AR: allergic rhinitis; HC: healthy control; MAR: mild allergic rhinitis; MSAR: moderate-severe allergic rhinitis.</div>

Mediators of Inflammation

fig1

Figure 1

Figure 1: Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients 

Figure 1 | Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients 